Lung transplantation for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: A single-center experience

Transplantation

Volumn 95, Issue 4, 2013, Pages 623-628

  Vogl, Ursula M ^a   Nagayama, Kazuhiro ^a,b   Bojic, Marija ^a   Hoda, Mir Ali Reza ^a   Klepetko, Walter ^a   Jaksch, Peter ^a   Dekan, Sabine ^a   Siersch, Viktoria ^a   Mitterbauer, Margit ^a   Schellongowski, Peter ^a   Greinix, Hildegard T ^a   Petkov, Ventzislav ^a   Schulenburg, Axel ^a   Kalhs, Peter ^a   Rabitsch, Werner ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Bronchiolitis obliterans; Hematopoietic stem cell transplantation; Lung transplantation

Indexed keywords

BUSULFAN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; FLUDARABINE; GANCICLOVIR; HYDROXYUREA; IDARUBICIN; METHYLPREDNISOLONE; MITOXANTRONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RECOMBINANT ALPHA2C INTERFERON; RITUXIMAB; TACROLIMUS; THALIDOMIDE; VALGANCICLOVIR;

ACUTE GRAFT REJECTION; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AIRWAY OBSTRUCTION; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BRONCHIOLITIS OBLITERANS; CHRONIC GRAFT REJECTION; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL EVALUATION; CONSOLIDATION CHEMOTHERAPY; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; DRUG MEGADOSE; DRUG TREATMENT FAILURE; DYSPNEA; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HEMATOLOGIC MALIGNANCY; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPOXEMIA; IMMUNOSUPPRESSIVE TREATMENT; INDUCTION CHEMOTHERAPY; LUNG TRANSPLANTATION; LYMPHOBLASTOMA; MALE; MULTIPLE ORGAN FAILURE; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PNEUMOCYSTIS PNEUMONIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PUVA; RADIATION DOSE; SALVAGE THERAPY; SEPSIS; SURVIVAL TIME; SYSTEMIC MYCOSIS; TREATMENT DURATION; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ACUTE DISEASE; ADOLESCENT; ADULT; AUSTRIA; BRONCHIOLITIS OBLITERANS; CHRONIC DISEASE; DRUG RESISTANCE; FEMALE; GRAFT REJECTION; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOLYTIC-UREMIC SYNDROME; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84874654337     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318277e29e     Document Type: Article

References (37)

1. Armitage JO. Bonemarrow transplantation.NEngl JMed 1994; 330: 827.
2. Schmitz N, Eapen M, Horowitz MM, et al. Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Blood 2006; 108: 4288.
3. Chiodi S, Spinelli S, Ravera G, et al. Quality of life in 244 recipients of allogeneic bone marrow transplantation. Br J Haematol 2000; 110: 614.
4. Kiss TL, Abdolell M, Jamal N, et al. Long-term medical outcomes and quality-of-life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation. J Clin Oncol 2002; 20: 2334.
5. Socie G. Graft-versus-host diseaseYfrom the bench to the bedside? N Engl J Med 2005; 353: 1396.
6. Chang YJ, Weng CL, Sun LX, et al. Allogeneic bone marrow transplantation compared to peripheral blood stem cell transplantation for the treatment of hematologic malignancies: a meta-analysis based on time-to-event data from randomized controlled trials. Ann Hematol 2012; 91: 427.
7. Schwarer AP, Hughes JM, Trotman-Dickenson B, et al. A chronic pulmonary syndrome associated with graft-versus-host disease after allogeneic marrow transplantation. Transplantation 1992; 54: 1002.
8. Chien JW. Preventing and managing bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation. Expert Rev Respir Med 2011; 5: 127.
9. Nakaseko C, Ozawa S, Sakaida E, et al. Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation. Int J Hematol 2011; 93: 375.
10. Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945.
11. Dudek AZ, Mahaseth H, DeFor TE, et al. Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes. Biol Blood Marrow Transplant 2003; 9: 657.
12. Hildebrandt GC, Fazekas T, Lawitschka A, et al. Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD. Bone Marrow Transplant 2011; 46: 1283.
13. Lucid CE, Savani BN, Engelhardt BG, et al. Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT. Bone Marrow Transplant 2011; 46: 426.
14. Morrell MR, Despotis GJ, Lublin DM, et al. The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant 2010; 29: 424.
15. Oyan B, Koc Y, Emri S, et al. Improvement of chronic pulmonary graft-vs-host disease manifesting as bronchiolitis obliterans organizing pneumonia following extracorporeal photopheresis. Med Oncol 2006; 23: 125.
16. Tun HW, Wallace KH, Grinton SF, et al. Etanercept therapy for lateonset idiopathic pneumonia syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation. Transplant Proc 2005; 37: 4492.
17. Fullmer JJ, Fan LL, Dishop MK, et al. Successful treatment of bronchiolitis obliterans in a bone marrow transplant patient with tumor necrosis factor-alpha blockade. Pediatrics 2005; 116: 767.
18. Lorillon G, Robin M, Meignin V, et al. Rituximab in bronchiolitis obliterans after haematopoietic stem cell transplantation. Eur Respir J 2011; 38: 470.
19. Majhail NS, Schiffer CA, Weisdorf DJ. Improvement of pulmonary function with imatinib mesylate in bronchiolitis obliterans following allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2006; 12: 789.
20. Olivieri A, Locatelli F, Zecca M, et al. Imatinib for refractory chronic graft-versus-host disease with fibrotic features. Blood 2009; 114: 709.
21. Whitson BA, Shelstad RC, Hertz MI, et al. Lung transplantation after hematopoietic stem cell transplantation. Clin Transplant 2012; 26: 254.
22. Koenecke C, Hertenstein B, Schetelig J, et al. Solid organ transplantation after allogeneic hematopoietic stem cell transplantation: a retrospective, multicenter study of the EBMT. Am J Transplant 2010; 10: 1897.
23. Martin PJ, Weisdorf D, Przepiorka D, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report. Biol Blood Marrow Transplant 2006; 12: 491.
24. Crawford SW, Clark JG. Bronchiolitis associated with bone marrow transplantation. Clin Chest Med 1993; 14: 741.
25. Paz HL, Crilley P, Patchefsky A, et al. Bronchiolitis obliterans after autologous bone marrow transplantation. Chest 1992; 101: 775.
26. Yoshihara S, Tateishi U, Ando T, et al. Lower incidence of Bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning. Bone Marrow Transplant 2005; 35: 1195.
27. Rabitsch W, Deviatko E, Keil F, et al. Successful lung transplantation for bronchiolitis obliterans after allogeneic marrow transplantation. Transplantation 2001; 71: 1341.
28. Bunin N, Guzikowski V, Rand ER, et al. Solid organ transplants following hematopoietic stem cell transplant in children. Pediatr Transplant 2010; 14: 1030.
29. Calhoon JH, Levine S, Anzueto A, et al. Lung transplantation in a patient with a prior bone marrow transplant. Chest 1992; 102: 948.
30. Gascoigne A, Corris P. Lung transplants in patients with prior bone marrow transplants. Chest 1994; 105: 327.
31. Okumura H, Ohtake S, Ontachi Y, et al. Living-donor lobar lung transplantation for broncho-bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: does bronchiolitis obliterans recur in transplanted lungs? Int J Hematol 2007; 86: 369.
32. Heath JA, Kurland G, Spray TL, et al. Lung transplantation after allogeneic marrow transplantation in pediatric patients: the Memorial Sloan-Kettering experience. Transplantation 2001; 72: 1986.
33. Trulock EP, Edwards LB, Taylor DO, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult lung and heart-lung transplantation reportY2006. J Heart Lung Transplant 2006; 25: 880.
34. Greinix HT, Loddenkemper C, Pavletic SZ, et al. Diagnosis and staging of chronic graft-versus-host disease in the clinical practice. Biol Blood Marrow Transplant 2011; 17: 167.
35. Orens JB, Estenne M, Arcasoy S, et al. International guidelines for the selection of lung transplant candidates: 2006 updateYa consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006; 25: 745.
36. Aigner C, Wisser W, Taghavi S, et al. Institutional experience with extracorporeal membrane oxygenation in lung transplantation. Eur J Cardiothorac Surg 2007; 31: 468; discussion 73Y4.
37. Jaksch P, Zweytick B, Kerschner H, et al. Cytomegalovirus prevention in high-risk lung transplant recipients: comparison of 3-vs 12-month valganciclovir therapy. J Heart Lung Transplant 2009; 28: 670.